SEARCH

SEARCH BY CITATION

References

  • 1
    NAPRTCS 2004 Annual Report. Available online at: https://web.emmes.com/study/pedpannlrept/annlrept2004.pdf (accessed March 10, 2009).
  • 2
    Yoshikawa N, Ito H, Akamatsu R, et al. Focal segmental glomerulosclerosis with and without nephrotic syndrome in children. J Pediatr 1986: 109: 6570.
  • 3
    Hariharan S, Savin V. Recurrent and de novo disease after renal transplantation: A report from the renal allograft disease registry. Pediatr Transplant 2004: 8: 349350.
  • 4
    Sener A, Bella AJ, Nguan C, Luke PP, House AA. Focal segmental glomerular sclerosis in renal transplant recipients: Predicting early disease recurrence may prolong allograft function. Clin Transplant 2009: 23: 96100.
  • 5
    Canaud G, Zuber J, Sberro R, et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: A pilot study. Am J Transplant 2009: 9: 10811086.
  • 6
    Streigel JE, Sibley RK, Fryd DS, Mauer M. Recurrence of focal segmental glomerulosclerosis in children following renal transplantation. Kidney Int 1986: 30(Suppl 19): S44S50.
  • 7
    Kim EM, Streigel J, Kim Y, Matas AJ, Najarian JS, Mauer SM. Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with acute renal failure and acute rejection. Kidney Int 1994: 45: 14401445.
  • 8
    Ponticelli C. Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant 2010: 25: 2531.
  • 9
    Abbott KC, Sawyers ES, Oliver JD 3rd, et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001: 37: 366373.
  • 10
    Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001: 59: 328333.
  • 11
    Baum MA. Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004: 8: 329333.
  • 12
    Cravedi P, Kopp JB, Remuzzi G. Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant 2013: 63: 266274.
  • 13
    Chang JW, Pardo V, Sageshima J, et al. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis. Transplantation 2012: 93: 12381244.
  • 14
    Bartosh SM, Stablein DM, Fine RN. Recurrence of focal segmental glomerulosclerosis (FSGS) following pediatric kidney transplantation in the modern immunosuppression era: A report from the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Submitted for presentation at the American Transplant Congress, Boston, Massachusetts, May 2004.
  • 15
    Canaud G, Martinez F, Noël LH, Mamzer MF, Niaudet P, Legendre C. Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev 2010: 24: 121128.
  • 16
    Shishido S, Satou H, Muramatsu M, et al. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation. Clin Transplant 2013: 27: E143E150.
  • 17
    Sethna C, Benchimol C, Hotchkiss H, et al. Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab. J Transplant 2011: 389542. doi: 10.1155/2011/389542.
  • 18
    Stewart ZA, Shetty R, Nair R, Reed AI, Brophy PD. Case report: Successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen. Transpl Proc 2011: 43: 39943996.
  • 19
    Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996: 334: 878883.
  • 20
    Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994: 330: 714.
  • 21
    Artero M, Biava C, Amen W, Tomlanovich S, Vincenti F. Recurrent focal glomerulosclerosis: Natural history and response to therapy. Am J Med 1992: 92: 375383.
  • 22
    Mahesh S, Del Rio M, Feuerstein D, et al. Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal segmental glomerulosclerosis: A single center experience. Pediatr Transplant 2008: 12: 682688.
  • 23
    Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review. Pediatr Transplant 2010: 14: 314325.
  • 24
    Fine R. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 2007: 22: 496502.
  • 25
    Schacter AD, Harmon WE. Single center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant 2001: 5: 406409.
  • 26
    Cochat P, Schell M, Ranchin B, Boueva A, Saïd MH. Management of recurrent nephrotic syndrome after kidney transplantation. Clin Nephrol 1996: 46: 1720.
  • 27
    Saleem MA, Ramanan AV, Rees L. Recurrent focal segmental glomerulosclerosis in grafts treated with plasma exchange and increased immunosuppression. Pediatr Nephrol 2000: 14: 361364.
  • 28
    Cochat P, Kassir A, Colon S, et al. Recurrent nephrotic syndrome after transplantation: Early treatment with plasmapheresis and cyclophosphamide. Pediatr Nephrol 1993: 7: 5054.
  • 29
    Dantal J, Baatard R, Hourmant M, Cantarovich D, Buzelin F, Soulillou JP. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. A one-center study of plasma exchange effects. Transplantation 1991: 52: 827831.
  • 30
    Greenstein SM, Delrio M, Ong E, et al. Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol 2000: 14: 10611065.
  • 31
    Cochat P, Fargue S, Mestrallet G, et al. Disease recurrence in paediatric renal transplantation. Pediatr Nephrol 2009: 24: 20972108.
  • 32
    Pradhan M, Petro J, Palmer J, Meyers K, Baluarte HJ. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 2003: 18: 934938.
  • 33
    Morath C, Wei C, Macher-Goepinger S, Schwenger V, Zeier M, Reiser J. Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification. Am J Ther 2013: 20: 226229.
  • 34
    Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011: 17: 952960.
  • 35
    Odorico JS, Knechtle SJ, Rayhill SC, et al. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996: 61: 228234.